Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease.
about
Therapy-related myeloid neoplasms - what have we learned so far?Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission.Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomesIncidence of secondary neoplasms in patients with acute promyelocytic leukemia treated with all-trans retinoic acid plus chemotherapy or with all-trans retinoic acid plus arsenic trioxideHigh-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.Second malignancies after autologous haematopoietic stem cell transplantation following modified BEAM conditioning regimen in patients with Hodgkin lymphoma - characteristics and risk factor analysis.Secondary Malignant Neoplasms Following Haematopoietic Stem Cell Transplantation in ChildhoodAccelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma.Therapy-related myelodysplasia and acute myeloid leukemiaTherapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients.Accelerated Total Lymphoid Irradiation-containing Salvage Regimen for Patients With Refractory and Relapsed Hodgkin Lymphoma: 20 Years of Experience.High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: long-term results.Allogeneic Hematopoietic Stem Cell Transplantation In Therapy-Related Myeloid Neoplasms (t-MN) of the Adult: Monocentric Observational Study and Review of the Literature.
P2860
Q28071318-7363D792-45DE-43D4-BC0A-C6FC42230EE3Q33705446-2D5BB738-620E-4093-A9F9-7695B45CF6DFQ34102941-9993B2F1-8B16-456E-BC4D-8DDEE955F39FQ35036840-4923655C-CCB6-4120-B596-4BAF7B04D240Q35563628-DEA7699B-B584-4463-AE88-9713C02179B7Q36619788-B88F8DF4-CCC3-406B-96ED-B1217D610FF3Q36936841-222CE381-C076-4EFB-A3A3-A36844255C6EQ37055896-9B0DB217-1338-413B-9526-9ABEBFC26689Q37103073-28C58385-0DD0-4E81-B197-87897BB89247Q37402657-0841EC47-0533-4A55-89D0-0908CDE211F3Q37548821-A548DFED-3091-46B8-92EA-1760BB6906F6Q39195424-473A680F-2AF2-4050-99EB-D2179AA90BE5Q43199533-43510183-EF13-495D-9B6A-ADA87EB27A9DQ49233865-A4199EC4-9D82-403A-AFBA-B3009137623F
P2860
Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Treatment-related deaths and s ...... ntation for Hodgkin's disease.
@en
Treatment-related deaths and s ...... ntation for Hodgkin's disease.
@nl
type
label
Treatment-related deaths and s ...... ntation for Hodgkin's disease.
@en
Treatment-related deaths and s ...... ntation for Hodgkin's disease.
@nl
prefLabel
Treatment-related deaths and s ...... ntation for Hodgkin's disease.
@en
Treatment-related deaths and s ...... ntation for Hodgkin's disease.
@nl
P2093
P1433
P1476
Treatment-related deaths and s ...... ntation for Hodgkin's disease.
@en
P2093
Colombat P
Gisselbrecht C
Henry-Amar M
P304
P407
P577
1998-09-01T00:00:00Z